FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of increasing the solubility of triazavirin, characterized by the following: to obtain an aqueous solution of triazavirin with a concentration of up to 8% wt./vol. an aqueous solution of meglumine is added to triazavirin at a concentration of 2 to 10% w/v. at a temperature not lower than 25°C, then the resulting mixture with stirring at least once every 15 minutes, is kept for 2 hours until triazavirin is completely dissolved, after which possible mechanical impurities are removed by filtration.
EFFECT: invention provides an aqueous solution of triazavirin with a concentration of up to 8%.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING HIGHLY CONCENTRATED SOLUTION OF RIAMILOVIR | 2024 |
|
RU2830367C1 |
METHOD FOR INCREASING CALCIUM SUCCINATE, CALCIUM MALATE AND CALCIUM CITRATE SOLUBILITY FOR CHILD'S MEDICINAL FORMULATIONS | 2006 |
|
RU2313350C1 |
METHOD FOR PREPARING SUBMICRON PACLITAXEL PARTICLES | 2004 |
|
RU2402313C2 |
WATER-SOLUBLE COMPOSITION, POSSESSING ANTI-TUMOUR ACTIVITY AND METHOD FOR OBTAINING THEREOF | 2015 |
|
RU2611362C1 |
LYOPHILIZED COMPOSITION BASED ON HGF | 2015 |
|
RU2693472C2 |
METHOD FOR COACERVATION OF DIHYDROQUERCETIN | 2023 |
|
RU2805649C1 |
METHOD FOR PREPARING SORBENT | 2005 |
|
RU2316393C2 |
METHOD FOR PREPARING HUMAN INSULIN COMBINED PREPARATION | 2002 |
|
RU2261108C2 |
METHOD FOR OBTAINING OF PEPTIDE IMMUNITY STIMULATOR (VERSIONS) AND BAA BASED THEREON | 2016 |
|
RU2635625C1 |
METHOD OF PRODUCTION, USE AND COMPOSITION OF MINOR SPHERICAL PARTICLES PRODUCED IN CONTROLLED PHASE SEPARATION | 2004 |
|
RU2426590C2 |
Authors
Dates
2023-12-27—Published
2023-04-05—Filed